ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy
Lung Diseases
Disease

Asthma trials near San Francisco, CA, USA:

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation...

Active, not recruiting
Asthma Acute
Combination Product: Rademikibart in prefilled syringe
Drug: Matching placebo in prefilled syringe

Phase 2

Connect Biopharm LLC

Palo Alto, California, United States and 57 other locations

This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...

Active, not recruiting
Asthma (Diagnosis)
Drug: Placebo
Drug: WIN378

Phase 2

Windward Bio

San Jose, California, United States and 72 other locations

This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma....

Enrolling
Mild to Moderate Asthma
Drug: CDX-622

Phase 1

Celldex Therapeutics
Celldex Therapeutics

San Francisco, California, United States and 3 other locations

and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroi...

Enrolling
Asthma
Drug: ENV-294
Drug: Placebo

Phase 2

Enveda Therapeutics

San Jose, California, United States of America and 18 other locations

immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...

Active, not recruiting
Asthma
Drug: Placebo
Drug: APG777

Phase 1

Apogee Therapeutics, Inc.

San Jose, California, United States of America and 12 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Napa, California, United States and 335 other locations

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...

Active, not recruiting
Asthma
Biological: NSI-8226
Biological: Placebo

Phase 2

Uniquity One (UNI)

San Jose, California, United States of America and 70 other locations

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting
Severe Asthma
Drug: Verekitug
Drug: Placebo

Phase 2

Upstream Bio

Walnut Creek, California, United States and 101 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

San Jose, California, United States and 133 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Walnut Creek, California, United States and 131 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems